论文部分内容阅读
目的:观察阿奇霉素治疗小儿呼吸道感染的临床疗效。方法:随机选取我院2012年6月～2013年6月份收治小儿呼吸道感染患儿272例,分为对照组和观察组各136例,对照组采用阿莫西林克拉维酸钾注射液每天1次静脉注射,观察组采用阿奇霉素注射液每天1次静脉注射,1个疗程为5天,比较2组临床疗效以及不良反应。结果:观察组小儿呼吸道感染治愈率为97.8%明显高于对照组治愈率89.7%,观察组患儿出现不良反应为3.7%明显低于对照组9.5%。结论:阿奇霉素治疗小儿呼吸道感染临床疗效显著,治疗安全、可靠、副作用小,值得临床推广使用。
Objective: To observe the clinical effect of azithromycin in treating children respiratory tract infection. Methods: A total of 272 children with respiratory tract infection in children admitted to our hospital from June 2012 to June 2013 were randomly divided into control group (136 cases) and observation group (136 cases). The control group was treated with amoxicillin and clavulanate potassium injection once daily Intravenous injection, the observation group using azithromycin injection once a day intravenously, a course of 5 days, the clinical efficacy and adverse reactions in two groups were compared. Results: The cure rate of children with respiratory tract infection in observation group was 97.8%, which was significantly higher than that of control group (89.7%). The incidence of adverse reactions in observation group was 3.7%, which was significantly lower than that of control group (9.5%). Conclusion: The therapeutic effect of azithromycin on respiratory tract infection in children is remarkable. The treatment is safe, reliable and the side effects are small. It is worth to be used clinically.